Cardiocomm Solutions Inc(EKG-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.015
Day High0.015
Open:0.015
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration
CardioComm Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Upcoming Meeting Dates - January 26, 2026
CardioComm Receives TSX Venture Exchange Approval for Announced Loan Facility
CardioComm Terminates Royalty Agreement and Enters into $512,000 Insider Loan Facility to Advance Gems Flex and 14-Day Holter/LTCM Platform
CardioComm Solutions Announces Royalty-Based Financing Deal
CardioComm Solutions Inc. Announces Insider Purchase of Third-party Loan
CardioComm Solutions Closes Shares for Debt Transactions
CardioComm Solutions Announces Intention to Settle Outstanding Debt with Issuance of Shares
CardioComm Solutions Provides AGM Update Regarding Canada Post Strike
CardioComm Solutions Integrates ECG Technology into Sony's mSafety Platform
Canadian Investment Regulatory Organization Trade Resumption - EKG
CardioComm Solutions Awarded Canadian Space Agency Contract for Design of Next Generation Connected Care Medical Module Prototype
Canadian Investment Regulatory Organization Trading Halt - EKG
CardioComm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias

Profile

CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.